News
Israeli digital health device maker TytoCare raised $11 million in a round led by Cambia Health Solutions.
Chicago-based Opternative has launched an online refractive eye exam service that helps consumers get prescriptions for glasses or contacts.
Nike and Apple have agreed to settle a class action lawsuit, first filed two years ago, that claimed the companies made misleading statements about the Nike+ FuelBand's ability to track calories, steps, and NikeFuel.
The National Cybersecurity Center of Excellence (NCCoE), a division of the National Institute of Standards and Technology (NIST) has penned a five-part draft guidance on cybersecurity for mobile devices that connect to electronic health records.
HelpAround, the Israel-based startup that raised $550,000 last year to bring the sharing economy to diabetes care, has launched a new app, Alert, which uses HealthKit data in realtime to provide support to patients.
Just over half of ambulatory practice physicians (52 percent) use a mobile device to access patient records or reference data according to a new survey of more than 6,000 physicians from Black Book Market Research.
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
In the company’s second quarter earnings call, Under Armour CEO Kevin Plank told investors that Under Armour is the ideal company to create a connected health dashboard for consumers.
Physicians Interactive (PI), the digital health marketing company that offers medical reference apps and resources like Omnio to physicians, has acquired Waltham, Massachusetts-based Quantia Communications, parent company of physician social network QuantiaMD.
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim.